LOTUSEYE · Lotus Eye Hospital and Institute Ltd · Healthcare Facilities
LOTUSEYE · Lotus Eye Hospital and Institute Ltd · Healthcare Facilities
As of 06 Nov close
52-week range
29.2% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 53 days old
Revenue (latest Q)
₹17 Cr
Revenue YoY
PAT YoY
+13.0%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
3.8
P/S (TTM)
4.1
Sector P/E
29.7
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| LOTUSEYE (this stock) | 1,654.9 | 3.8 | +0.3% | +0.3% | 0.26 | 0.0% |
| Apollo Hospitals Enterprise | 64.9 | 13.4 | +7.8% | +21.9% | 53.8 | +0.2% |
| Max Healthcare Institute | 71.5 | 9.9 | +17.2% | +14.3% | 27.71 | +0.2% |
| Fortis Healthcare | 69 | 14.6 | +11.0% | +10.6% | 0.35 | +0.1% |
Promoter
stable
FII
stable
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedThe annual report of Lotus Eye Hospital and Institute Limited highlights the company's commitment to upholding the legacy of its founder, Dr. S.K. Sundaramoorthy, through quality eye care services and stakeholder satisfaction. The report mentions the expansion of operations with the opening of a new eye care center in Gobichettipalayam, which contributed to increased turnover but also led to a decline in net profit due to initial expansion costs. The company emphasizes its adherence to corporate governance, risk management, and compliance with regulatory requirements, including the establishment of internal controls and audit processes. Additionally, the report outlines the company's efforts in energy conservation and the implementation of IT systems to enhance operational efficiency.
- Commitment to legacy and quality eye care services as established by the founder
- Expansion of operations with a new eye care center leading to increased turnover but initial profit decline
- Focus on corporate governance, risk management, and regulatory compliance
Key takeaway: The company is expanding its operations and maintaining a strong focus on corporate governance and quality services, despite facing challenges related to initial expansion costs and rising operational expenses.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
1 occurrenceEarlier (1-3 years ago)
The company has ongoing disputes with tax authorities and forum mainly relating to treatment of characterization and classification of certain items. The company has demands amounting to Rs. 82.17 Lakhs and Rs. 84.20 Lakhs as at March 31, 2025 and 2024, respectively.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
40.79% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).